Common Name |
Tolterodine
Description |
Tolterodine is only found in individuals that have used or taken this drug. It is an antimuscarinic drug that is used to treat urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors.Both tolterodine and its active metabolite, 5-hydroxymethyltolterodine, act as competitive antagonists at muscarinic receptors. This antagonism reslits in inhibition of bladder contraction, decrease in detrusor pressure, and an incomplete emptying of the bladder.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
(+)-(R)-2-(alpha-(2-(diisopropylamino)Ethyl)benzyl)-P-cresolChEBI
(+)-TolterodineChEBI
TolterodinaChEBI
TolterodinumChEBI
(+)-(R)-2-(a-(2-(diisopropylamino)Ethyl)benzyl)-P-cresolGenerator
(+)-(R)-2-(α-(2-(diisopropylamino)ethyl)benzyl)-P-cresolGenerator
Tolterodine extended release capsliesHMDB
Tolterodine L-tartrateHMDB
Tolterodine tartrateHMDB
Tolterondine tartrateHMDB
Tartrate, tolterodineMeSH
DetrolMeSH
Detrol laMeSH
UrotrolMeSH
LA, detrolMeSH
UnidetMeSH
DetrusitolMeSH
Chemical Formlia |
C22H31NO
Average Molecliar Weight |
325.4876
Monoisotopic Molecliar Weight |
325.240564619
IUPAC Name |
2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
Traditional Name |
(+)-tolterodine
CAS Registry Number |
124937-51-5
SMILES |
CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
InChI Identifier |
InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1
InChI Key |
OOGJQPCLVADCPB-HXUWFJFHSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.
Kingdom |
Organic compounds
Super Class |
Benzenoids
Class |
Benzene and substituted derivatives
Sub Class |
Diphenylmethanes
Direct Parent |
Diphenylmethanes
Alternative Parents |
Para cresols
Toluenes
Aralkylamines
1-hydroxy-2-unsubstituted benzenoids
Trialkylamines
Organopnictogen compounds
Organooxygen compounds
Hydrocarbon derivatives
Substituents |
Diphenylmethane
P-cresol
1-hydroxy-2-unsubstituted benzenoid
Phenol
Aralkylamine
Toluene
Tertiary amine
Tertiary aliphatic amine
Amine
Hydrocarbon derivative
Organopnictogen compound
Organic oxygen compound
Organooxygen compound
Organonitrogen compound
Organic nitrogen compound
Aromatic homomonocyclic compound
Molecliar Framework |
Aromatic homomonocyclic compounds
External Descriptors |
tertiary amine (CHEBI:9622 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Anti-Incontinence Agents
Antispasmodics
Genitourinary Smooth Muscle Relaxants
Muscarinic Antagonists
Application |
Pharmaceutical
Cellliar locations |
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility5.34e-03 g/LNot Available
LogP5.6Not Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.0053 mg/mLALOGPS
logP5.39ALOGPS
logP5.12ChemAxon
logS-4.8ALOGPS
pKa (Strongest Acidic)10.28ChemAxon
pKa (Strongest Basic)11.01ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area23.47 Å2ChemAxon
Rotatable Bond Count7ChemAxon
Refractivity103.96 m3·mol-1ChemAxon
Polarizability39.27 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
LC-MS/MS |
LC-MS/MS Spectrum – , positivesplash10-000t-2911000000-6586d7c95e03f623dbf4View in MoNA
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01036
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01036
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB01036
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
391967
KEGG Compound ID |
C07750
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Tolterodine
NuGOwiki Link |
HMDB15170
Metagene Link |
HMDB15170
METLIN ID |
Not Available
PubChem Compound |
443879
PDB ID |
Not Available
ChEBI ID |
9622
Product: NMS-1286938
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
Not Available |
PMID: 26295339